HIV microbicide study gets FDA approval
BY Advocate.com Editors
August 06 2003 12:00 AM ET
The Food and Drug Administration on Monday gave approval to Australia-based Starpharma to begin human trials in the U.S. of its HIV microbicide gel called VivaGel, CNN.com reports. The compound was shown to be 100% effective in animals in preventing HIV, genital herpes, and chlamydia infections. The gel will be studied in women for the prevention of vaginal HIV infections. The company hasn't commented on whether the compound will be evaluated to prevent HIV infections through anal sex. Starpharma officials say if the trials are successful, a prescription-only version of the product could be available within three years, with an over-the-counter version possible in about five years.
- Op-ed: Be a Lady, Not a Tramp
- Michael Sam Released From Dallas Cowboys, Vows to Fight for Opportunity to 'Play Every Sunday'
- Playwright Responds to N.C. High School That Canceled Play Due to Gay Scene
- Shonda Rhimes to Antigay Viewer: 'Bye Felicia'
- Last-Minute Gift Ideas for the Catholic Who Suddenly Wants to Be Friends
- #TBT: They Died in the Closet